Tag: Revolution Medicines

Browse exclusive Tags!

INVO Bioscience to Acquire NAYA Biosciences in All-Stock Deal, Shares Surge

Discover the latest developments in the business and finance world, from surging shares and strategic acquisitions to setbacks and challenges.

Revolution Medicines Acquires EQRx, Adding $1B in Net Cash for RAS Cancer Drug Development, United States

Revolution Medicines acquires EQRx to strengthen oncology efforts. This all-stock deal provides over $1 billion in net cash for innovative drug development.

Popular

INVO Bioscience to Acquire NAYA Biosciences in All-Stock Deal, Shares Surge

Discover the latest developments in the business and finance world, from surging shares and strategic acquisitions to setbacks and challenges.

Subscribe

spot_imgspot_img